Core Viewpoint - The company reported a significant increase in revenue and a reduction in net loss, indicating resilience and growth in a challenging economic environment [1] Financial Performance - Revenue for the six months ending June 30, 2025, increased by 27.1% to RMB 153 million [1] - The net loss attributable to equity shareholders narrowed by 31.8% to RMB 40.9 million [1] - The diluted loss per share decreased from RMB 0.17 to RMB 0.10, a reduction of RMB 0.07 [1] Company Overview - The company is a leading player in the development, manufacturing, and commercialization of collaborative robots [1] - It has a comprehensive self-research technology capability and a diverse product matrix, with applications across various sectors including industrial manufacturing, retail, medical surgery, health therapy, and education [1] - The company operates in over 100 countries and regions globally [1] Strategic Initiatives - In 2025, the company plans to fully enter the embodied intelligence sector, aiming to be the first globally to launch a "robotic arm + humanoid + multi-legged" full-form embodied robot platform [1] - The company is pursuing a dual strategy of "collaborative robot intelligent upgrade + embodied intelligent robot innovation" to drive product and technological breakthroughs [1]
越疆(02432.HK)中期营业收入同比增加27.1%至1.53亿元